Matthew Gline is Chief Executive Officer of Roivant Sciences Ltd. (ROIV). The company reported total compensation of $163,293,744 for fiscal year 2024.
| Salary | $725,000 |
|---|---|
| Bonus | $4,978,875 |
| Stock awards | $157,577,851 |
| Option awards | — |
| Non-equity incentive plan | — |
| Pension and non-qualified deferred compensation | — |
| All other compensation | $12,018 |
| Total | $163,293,744 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Roivant Sciences Ltd. filed July 29, 2025, accession 0001140361-25-027846.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2024 | Chief Executive Officer | $725,000 | $4,978,875 | $157,577,851 | — | — | — | $12,018 | $163,293,744 |
| FY2023 | Chief Executive Officer | $725,000 | $0 | $0 | $0 | $0 | $0 | $13,189 | $738,189 |
| FY2022 | Chief Executive Officer | $725,000 | $1,036,750 | — | $47,206,737 | — | — | $10,339 | $48,978,825 |
Totals as disclosed in each year's own compensation disclosure for Roivant Sciences Ltd..
| Peer-group chief executive median | $11,225,426 |
|---|---|
| Difference from that median | $152,068,318 |
| Percentile within the disclosed peer group | 99th |
| Peers with a disclosed figure | 21 |
Medians and percentiles are computed across the peer group Roivant Sciences Ltd. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2024 total |
|---|---|---|
| Mayukh Sukhatme | President and Chief Investment Officer | $251,858,764 |
| Matthew Gline this page | Chief Executive Officer | $163,293,744 |
| Eric Venker | President and Immunovant CEO | $11,807,422 |
| Rakhi Kumar | Former Chief Accounting Officer | $4,693,938 |
| Richard Pulik | Chief Financial Officer | $4,127,151 |
| Jennifer Humes | Chief Accounting Officer | $2,382,956 |
The company's named executive officers for fiscal year 2024, and what it reported for each. See the full Roivant Sciences Ltd. compensation brief.
Matthew Gline's compensation sits inside Roivant Sciences Ltd.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.